Aug 18, 2026 06:44AM
Jun 10, 2026 07:13AM
Jun 9, 2026 07:45AM
Jun 9, 2026 07:45AM
Jun 1, 2026 07:01AM
Jun 1, 2026 07:00AM
May 11, 2026 07:03AM Actuate Therapeutics gets FDA clearance for oral elraglusib trial
May 11, 2026 07:00AM
May 6, 2026 08:45AM
May 6, 2026 08:45AM
Apr 14, 2026 08:45AM
Apr 14, 2026 08:45AM
Mar 24, 2026 07:01AM
Mar 24, 2026 07:00AM Actuate Therapeutics: Poised for Potential $200M+ Pediatric Priority Review Vouchers and Transformative Combinations in RAS-Driven Cancers
Mar 9, 2026 08:45AM
Mar 4, 2026 05:00PM
Feb 24, 2026 08:45AM
Jan 21, 2026 08:45AM
Jan 21, 2026 08:45AM
Jan 12, 2026 08:45AM
Jan 12, 2026 08:45AM Actuate Therapeutics Reports Positive Follow-Up Data from its Randomized Controlled Phase 2 Trial Demonstrating Extended Long-Term Overall Survival Benefit with Elraglusib Plus Chemotherapy for Metast
Jan 6, 2026 02:26PM
Jan 6, 2026 08:45AM
Jan 6, 2026 08:45AM
Dec 18, 2025 08:45AM
Dec 18, 2025 08:45AM
Dec 15, 2025 08:45AM
Dec 15, 2025 08:45AM Actuate Therapeutics Announces Publication of Positive Phase II Clinical Data for Elraglusib Combined with Platinum Chemotherapy and Sequential Immunotherapy in Recurrent, Metastatic Salivary Gland Ca
Sep 23, 2025 06:37AM
Sep 22, 2025 08:45AM
Sep 22, 2025 08:45AM
Aug 26, 2025 01:08AM
Aug 6, 2025 08:45AM
Aug 6, 2025 08:45AM
Jul 21, 2025 06:46AM H.C. Wainwright Reiterates Buy Rating on Actuate Therapeutics (ACTU)
Jul 17, 2025 08:45AM
Jul 17, 2025 08:45AM
Jun 24, 2025 09:15AM
Jun 20, 2025 08:45AM
Jun 20, 2025 08:45AM
Jun 16, 2025 08:30AM
Jun 2, 2025 09:00AM Actuate Therapeutics Shares Highlights from KOL Event on Positive Topline Elraglusib Phase 2 Data in First-Line Treatment of Metastatic Pancreatic Cancer
May 31, 2025 04:30PM
May 22, 2025 05:29PM
May 22, 2025 05:05PM
May 7, 2025 08:00AM
May 6, 2025 08:01AM
May 6, 2025 08:00AM
Apr 30, 2025 08:00AM Actuate Therapeutics to Participate in Citizens Life Sciences Conference 2025
Apr 23, 2025 10:24AM

329,070 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All